September 2025
1. PILALA KM, Koroneou S, Papadimitriou MA, Panoutsopoulou K, et al
   Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.
   Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70147.
   

   >> Share

   
   June 2025
2. BEEREN I, Kiebach J, Hof JP, Buffart LM, et al
   Physical activity and risks of recurrence and progression among patients with non-muscle invasive bladder cancer.
   Int J Cancer. 2025 Jun 30. doi: 10.1002/ijc.70030.
   

   >> Share

   
   April 2025
3. YAMAMOTO A, Kawashima A, Uemura T, Nakano K, et al
   A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure.
   Int J Cancer. 2025;156:1439-1456.
   

   >> Share

   
   February 2025
4. 
   RETRACTION: Circular RNA CEP128 Promotes Bladder Cancer Progression by Regulating Mir-145-5p/Myd88 via MAPK Signaling Pathway.
   Int J Cancer. 2025 Feb 28. doi: 10.1002/ijc.35391.
   

   >> Share

   
   January 2025
5. MANN J, Niedermayer K, Krautstrunk J, Abbey L, et al
   Combined inhibition of RAD51 and CHK1 causes synergistic toxicity in cisplatin resistant cancer cells by triggering replication fork collapse.
   Int J Cancer. 2025;156:389-402.
   

   >> Share

   
   November 2024
6. KIEBACH J, Beeren I, Aben KKH, Witjes JA, et al
   Smoking behavior and the risks of tumor recurrence and progression in patients with non-muscle-invasive bladder cancer.
   Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35250.
   

   >> Share

   
   October 2024
7. SHARMA A, Kumari L, Ratre BK, Khan MA, et al
   Effect of anesthetic technique on antitumor immunity in patients undergoing surgery for gall bladder cancer: A prospective randomized comparative study.
   Int J Cancer. 2024 Oct 9. doi: 10.1002/ijc.35179.
   

   >> Share

   
   September 2024
8. NESIC M, Rasmussen MH, Henriksen TV, Demuth C, et al
   Beyond basics: Key mutation selection features for successful tumor-informed ctDNA detection.
   Int J Cancer. 2024;155:925-933.
   

   >> Share

   
   July 2024
9. DI BELLO F, Siech C, Jannello LMI, de Angelis M, et al
   Contemporary survival in metastatic bladder cancer patients: A population-based study.
   Int J Cancer. 2024 Jul 3. doi: 10.1002/ijc.35077.
   

   >> Share

   
   March 2024
10. ATALLAH A, Grossman A, Nauman RW, Pare JF, et al
    Systemic versus localized Bacillus Calmette Guerin immunotherapy of bladder cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity.
    Int J Cancer. 2024 Mar 14. doi: 10.1002/ijc.34897.
    

    >> Share

    
    September 2023
11. PRADHAN P, Jia G, Khankari NK, Zheng W, et al
    Evaluating interactions of polygenic risk scores and NAT2 genotypes with tobacco smoking in bladder cancer risk.
    Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34736.
    

    >> Share

    
    
12. SJODAHL G, Eriksson P, Holmsten K, Abrahamsson J, et al
    Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer.
    Int J Cancer. 2023 Sep 6. doi: 10.1002/ijc.34715.
    

    >> Share

    
    August 2023
13. YU EY, Tang QY, Chen YT, Zhang YX, et al
    Genome-wide exploration of genetic interactions for bladder cancer risk.
    Int J Cancer. 2023 Aug 28. doi: 10.1002/ijc.34690.
    

    >> Share

    
    May 2023
14. HOSSEINI B, Zendehdel K, Bouaoun L, Hall AL, et al
    Bladder cancer risk in relation to occupations held in a nationwide case-control study in Iran.
    Int J Cancer. 2023 May 9. doi: 10.1002/ijc.34560.
    

    >> Share

    
    March 2023
15. HIEN TT, Ambite I, Wan MLY, Cavalera M, et al
    Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy.
    Int J Cancer. 2023 Mar 9. doi: 10.1002/ijc.34500.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share